-
Written by
Bhavya Bhambani
Content Writer, 9M India
-
Reviewed by
Manish Agrawal
MD, 9M India Limited
-
Fact-checked by
Manish Shah
Plant Head, 9M India
Pharma Companies in India – Industry Context
Industry estimates for 2024 put India’s third-party pharma manufacturing market at ₹12,000–15,000 crore a year and growing at 12–15%. This market segment is serving hospital chains, foreign importers who want to sell high-quality pharmaceutical products under their brand name without having manufacturing facilities and domestic branded generic companies. The key differentiator for third-party manufacturers serving international markets is WHO-GMP certification.
From The Pharma Guide
6 things to check before choosing an injection manufacturer in India
WHO-GMP certificate expiry, molecule-level DCGI approval, sample COA availability within 24 hours,
export references in your target country, cleanroom grade classification, and documentation
turnaround - the buyer's six-point verification checklist.
Read the full checklist
#1 THIRD-PARTY MANUFACTURER IN INDIA 2026
Need third-party manufacturing?
Share your molecule, dosage form, and target market. We confirm manufacturing capability, pricing, and all export documentation within 24 hours.
-
200+ molecules — sterile injectables, capsules, tablets, syrups, eye drops, topicals
-
COPP issued in your brand name, not ours — build your own label
-
FSC, COA and CTD dossier — all within 24 hours
-
Active export to Kenya, Nigeria, UAE and 15+ countries
Talk to 9M India
Talk to 9M India
Looking for a WHO-GMP certified manufacturing partner with full documentation?
Share your molecule, strength, and target market. We confirm manufacturing capability, pricing, and all export documentation within 24 hours.
WHO-GMP certified · DCGI approved · 15+ export countries · Birkoni, Chhattisgarh · Est. 2009 · Reply guaranteed within 24 hours